NCT07081698 Walnuts as an Infant Solid Food for Health
| NCT ID | NCT07081698 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Colorado State University |
| Condition | Gut -Microbiota |
| Study Type | INTERVENTIONAL |
| Enrollment | 90 participants |
| Start Date | 2025-05-18 |
| Primary Completion | 2027-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 90 participants in total. It began in 2025-05-18 with a primary completion date of 2027-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The objective is to investigate the effect of walnuts on gut microbiota, inflammatory markers, atopic dermatitis status, and indices of allergy outcomes in breastfed infants during early complementary feeding. The three primary aims include: Aim 1: Evaluate the effect of walnut consumption on gut microbiota structure and function, inflammation, atopic dermatitis, and allergy outcomes. Aim 2: Evaluate the impact of walnut consumption on infant growth trajectories and risk of overweight. Aim 3 (exploratory): Identify walnut-specific food signatures that are associated with gut microbiota and immunity biomarkers using a novel nutri-metabolomics technique.
Eligibility Criteria
Inclusion Criteria: * Full term: gestational age ≥ 37 weeks * Generally healthy without conditions that would affect normal growth * No significant consumption of complementary food (e.g., no more than 1 oz of solid foods per week) * Exclusively breastfed (\< 2 weeks of cumulative formula exposure) Exclusion Criteria: * Adults unable to consent * Pregnant women * Prisoners
Contact & Investigator
Minghua Tang, Phd
PRINCIPAL INVESTIGATOR
Colorado State University
Frequently Asked Questions
Who can join the NCT07081698 clinical trial?
This trial is open to participants of all sexes, aged 5 Months or older, up to 5 Months, studying Gut -Microbiota. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07081698 currently recruiting?
Yes, NCT07081698 is actively recruiting participants. Contact the research team at Nathan.Campbell@colostate.edu for enrollment information.
Where is the NCT07081698 trial being conducted?
This trial is being conducted at Fort Collins, United States.
Who is sponsoring the NCT07081698 clinical trial?
NCT07081698 is sponsored by Colorado State University. The principal investigator is Minghua Tang, Phd at Colorado State University. The trial plans to enroll 90 participants.